We are live on ! Find out more
II

Inspire Investing Portfolio holdings

AUM $1.71B
1-Year Est. Return 31.76%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
+31.76%
3 Year Est. Return
+77.15%
5 Year Est. Return
+100.59%
10 Year Est. Return
AUM
$909M
AUM Growth
+$126M
Cap. Flow
+$36M
Cap. Flow %
3.96%
Top 10 Hldgs %
14.17%
Holding
835
New
44
Increased
530
Reduced
211
Closed
50

Top Sells

Rank Stock Value
1
IBD icon
Inspire Corporate Bond ETF
IBD
+$9.28M
2
CSL icon
Carlisle Companies
CSL
+$2.05M
3
NOV icon
NOV
NOV
+$1.51M
4
MUR icon
Murphy Oil
MUR
+$1.45M
5
BLDR icon
Builders FirstSource
BLDR
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Industrials 17.54%
3 Healthcare 11.39%
4 Financials 10.04%
5 Real Estate 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLG
401
Flagstar Bank National Association
FLG
$5.82B
$426K 0.05%
13,871
+3,386
+32% +$102K
NUS icon
402
Nu Skin
NUS
$267M
$425K 0.05%
21,880
+6,127
+39% +$113K
CMP icon
403
Compass Minerals
CMP
$1.15B
$424K 0.05%
16,747
+4,452
+36% +$114K
MATW icon
404
Matthews International
MATW
$739M
$424K 0.05%
11,564
-12,885
-53% -$472K
PENG
405
Penguin Solutions Inc
PENG
$2.99B
$423K 0.05%
22,344
-19,463
-47% -$337K
ASIX icon
406
AdvanSix
ASIX
$444M
$423K 0.05%
14,111
+2,889
+26% +$80.3K
CNK icon
407
Cinemark Holdings
CNK
$4.32B
$419K 0.05%
29,712
+10,040
+51% +$156K
OII icon
408
Oceaneering
OII
$4.77B
$418K 0.05%
19,621
+5,424
+38% +$120K
GPRE icon
409
Green Plains
GPRE
$1.03B
$417K 0.05%
16,525
+5,006
+43% +$132K
CR icon
410
Crane Co
CR
$12.7B
$412K 0.05%
3,485
-225
-6% -$22.7K
EXEL icon
411
Exelixis
EXEL
$13.4B
$409K 0.05%
17,046
-13,893
-45% -$302K
KOP icon
412
Koppers
KOP
$969M
$406K 0.04%
+7,927
New +$331K
VKTX icon
413
Viking Therapeutics
VKTX
$4B
$401K 0.04%
21,545
-6,102
-22% -$79.8K
IMKTA icon
414
Ingles Markets
IMKTA
$1.67B
$399K 0.04%
4,622
-3,394
-42% -$276K
MEDP icon
415
Medpace
MEDP
$16.5B
$396K 0.04%
1,292
-2,565
-67% -$692K
SGRY icon
416
Surgery Partners
SGRY
$2.03B
$396K 0.04%
12,364
-5,739
-32% -$167K
ICUI icon
417
ICU Medical
ICUI
$4.61B
$395K 0.04%
3,958
-524
-12% -$51.2K
TNC icon
418
Tennant Co
TNC
$1.26B
$395K 0.04%
4,256
+27
+0.6% +$2.24K
THC icon
419
Tenet Healthcare
THC
$21.1B
$393K 0.04%
5,205
+520
+11% +$33K
AWR icon
420
American States Water
AWR
$3.46B
$393K 0.04%
4,886
+889
+22% +$71.1K
FOLD
421
DELISTED
Amicus Therapeutics
FOLD
$393K 0.04%
27,672
+2,477
+10% +$28.1K
MSTR icon
422
Strategy Inc
MSTR
$38.4B
$393K 0.04%
6,220
-3,280
-35% -$155K
RDNT icon
423
RadNet
RDNT
$5.69B
$392K 0.04%
11,283
+385
+4% +$12.2K
UFPT icon
424
UFP Technologies
UFPT
$2.43B
$392K 0.04%
2,277
+362
+19% +$58.6K
FELE icon
425
Franklin Electric
FELE
$4.84B
$392K 0.04%
4,052
+531
+15% +$47.7K

Similar funds

Inspire Investing's Q4 2023 Portfolio in Review

As of Q4 2023, Inspire Investing held 835 positions worth $909M, up 16% from $783M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Inspire Investing deployed $36M of net new capital in Q4 2023, opening 44 new positions and adding to 530 existing holdings. Its largest new stake was Axcelis: 15,519 shares worth $2.01M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Inspire Corporate Bond ETF, an estimated $9.28M trimmed.

  • Inspire Investing's largest Q4 2023 buy was Axcelis: 15,519 shares worth $2.01M.
  • Inspire Investing added most to Inspire International ETF in Q4 2023, an estimated $2.49M increase.
  • Inspire Investing's biggest Q4 2023 reduction was Inspire Corporate Bond ETF, cutting an estimated $9.28M.
  • Inspire Investing fully exited NOV in Q4 2023, selling an estimated $1.51M.
  • Inspire Investing's ten largest holdings make up 14% of its $909M portfolio in Q4 2023.
  • Inspire Investing opened 44 new positions and closed 50 in Q4 2023.
  • Inspire Investing's portfolio value rose 16% quarter-over-quarter to $909M.

Based on Inspire Investing's 13F filing for Q4 2023, filed 12 Feb 2024.